Resistance to Complement Activation, Cell Membrane Hypersialylation and Relapses in Chronic Lymphocytic Leukemia Patients Treated With Rituximab and Chemotherapy

Oncotarget - United States
doi 10.18632/oncotarget.25657
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Cell-Free IgG-aggregates in Plasma of Patients With Chronic Lymphocytic Leukemia Cause Chronic Activation of the Classical Complement Pathway

PLoS ONE
Multidisciplinary
2020English

Prognostic Role of Translocator Protein and Oxidative Stress Markers in Chronic Lymphocytic Leukemia Patients Treated With Bendamustine Plus Rituximab

Oncology Letters
Cancer ResearchOncology
2014English

Management of Patients With Chronic Lymphocytic Leukemia Treated With Lenalidomide

Clinical Journal of Oncology Nursing
Oncology
2010English

A Phase I/Ii Study of Rituximab and Etanercept in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

DNA Methylation Profiles in Chronic Lymphocytic Leukemia Patients Treated With Chemoimmunotherapy

Clinical Epigenetics
GeneticsDevelopmental BiologyMolecular Biology
2019English

Incidence of Relapses Among Patients Treated With Antibiotics and Chemotherapy

Diseases of the Chest
1959English

Myocardial Contractility Dysfunction in Patients With Chronic Lymphocytic Leukemia Receiving Chemotherapy and Their Treatment With Enalapril

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2020English

Experience With Ibrutinib in Patients With Refractory and Recurrent B-Cell Chronic Lymphocytic Leukemia

Medical Council
2017English

Experience With Rituximab Immunotherapy as an Early Intervention in Patients With Rai Stage 0 to II Chronic Lymphocytic Leukemia

Cancer
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy